Sensorineural Hearing Loss Clinical Trial
Official title:
The Effect of Sound Stimulation on Hearing Ability
Verified date | April 2012 |
Source | Earlogic Korea, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
In the late 1990s, researchers discovered that acoustic stimuli slow progressive
sensorineural hearing loss and exposure to a moderately augmented acoustic environment can
delay the loss of auditory function. In addition, prolonged exposure to an augmented
acoustic environment could improve age-related auditory changes. These ameliorative effects
were shown in several types of mouse strains, as long as the acoustic environment was
provided prior to the occurrence of severe hearing loss.
In addition to delaying progressive hearing loss, acoustic stimuli could also protect
hearing ability against damage by traumatic noise. In particular, a method called forward
sound conditioning (i.e., prior exposure to moderate levels of sound) has been shown to
reduce noise-induced hearing impairment in a number of mammalian species, including humans.
Interestingly, recent report has suggested that low-level sound conditioning also reduces
free radical-induced damage to hair cells, increases antioxidant enzyme activity, and
reduces Cox-2 expression in cochlea, and can enhance cochlear sensitivity. Specifically,
increased cochlear sensitivity was observed when distortion product otoacoustic emissions
(DPOAEs) and compound action potentials (CAPs) were measured.
In addition to forward sound conditioning, backward sound conditioning (i.e., the use of
acoustic stimuli after exposure to a traumatic noise) has been shown to protect hearing
ability against acoustic trauma and to prevent the cortical map reorganization induced by
traumatic noise.
In this study, the investigators examine the effect of sound stimulation on hearing ability
in human subjects.
Status | Completed |
Enrollment | 21 |
Est. completion date | April 2012 |
Est. primary completion date | February 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 20 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Male and female - Age between 20 and 70 years - Subjects should be able to use an mp3 player Exclusion Criteria: - Hearing loss more than 70 dB HL at any frequency - More than 10 dB of air-bone gaps at more than 3 frequencies in pure-tone audiometry - Ear infections, chronic middle ear disease or any abnormality of the ear canal or ear drum - Temporary hearing loss - Hearing aid user - Pregnant females |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Earlogic Auditory Research Institute | Seoul |
Lead Sponsor | Collaborator |
---|---|
Earlogic Korea, Inc. |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes of pure-tone hearing thresholds after sound stimulation | Pure-tone hearing thresholds of the baseline and the final point (after 2~6 months)will be compared. | 2~6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00023036 -
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts
|
||
Completed |
NCT03746613 -
Clinal Evaluation of Navigation Based Functional Ear Surgery Using Image Guided and Robotically Assisted Techniques
|
N/A | |
Recruiting |
NCT05568329 -
Appreciation for Music Processed by Hearing Aids
|
N/A | |
Withdrawn |
NCT05061758 -
A Trial of LY3056480 in Patients With SNLH
|
Phase 2 | |
Completed |
NCT03212924 -
Listening Effort in Cochlear Implant Users
|
N/A | |
Recruiting |
NCT06053190 -
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
|
N/A | |
Completed |
NCT03718975 -
Quality Control of CE-Certified Phonak Hearing Aids - 2018_28
|
N/A | |
Completed |
NCT06025097 -
Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.
|
Early Phase 1 | |
Recruiting |
NCT04102215 -
The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure
|
N/A | |
Recruiting |
NCT04108598 -
The SeaSHeL National Prospective Cohort Study
|
||
Active, not recruiting |
NCT04750642 -
Cochlear Implant With Dexamethasone Eluting Electrode Array
|
N/A | |
Completed |
NCT04120116 -
FX-322 in Adults With Stable Sensorineural Hearing Loss
|
Phase 2 | |
Recruiting |
NCT06223724 -
Status Telemetry for Cochlear Implantations
|
||
Completed |
NCT02005822 -
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
|
Phase 3 | |
Suspended |
NCT02616172 -
Autologous Bone Marrow Harvest and Transplant for Sensorineural Hearing Loss
|
Phase 1/Phase 2 | |
Completed |
NCT02259595 -
Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
|
Phase 1 | |
Unknown status |
NCT01902914 -
Effectiveness of P02 Digital Hearing Aids
|
Phase 1/Phase 2 | |
Completed |
NCT00589511 -
Nucleus Freedom Cochlear Implant System Pediatric Post-approval Study
|
N/A | |
Completed |
NCT03288753 -
Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors
|
N/A | |
Completed |
NCT04462198 -
Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss
|
Phase 1/Phase 2 |